Our Stories
After Paul Beard's double lung transplant, the immunosuppressant drugs he needed led to skin cancers. Seeking a solution, Paul enrolled in the SiroSkin clinical trial.
When Illana Klevansky was diagnosed with ocular melanoma, the news was so traumatic that she started a journal to help process her thoughts and fears.
When Ana Ratapu was diagnosed with metastatic melanoma, she had to fight to access life-saving treatment. With the clock ticking and limited treatment options available in New Zealand, Ana made the decision that would save her life: move to Australia and join a clinical trial.
As a young doctor, Prof Mark Shackleton was focused on becoming a neurologist, until one day, he found himself on an oncology ward. Witnessing the profound challenges faced by cancer patients left a deep impact on him, igniting a passion for melanoma research.
When John was offered a place on the CHARLI trial to treat his stage IV melanoma, he didn't hesitate, especially as he could access the treatment near his home in regional Victoria.
When Allen Schnitzerling was diagnosed with Merkel cell carcinoma, his prognosis was dire. But after putting his faith in his doctors and their “special soup”, as he affectionally calls it, Allen is now planning adventurous holidays with his wife.
When Lisa, Jenny and Vikki immigrated to Australia in their younger years, they had no idea that the outdoor lifestyle they embraced would lead to a melanoma diagnosis later in life.
Stuart is a participant in the Melanoma Margins Trial
John, who has Merkel cell carcinoma, is participating in the I-MAT trial.
A lived experience with cancer inspired Paul White and Mary Tsouvalakis to join the MASC Trials Board.